Viridian Therapeutics Inc...

NASDAQ: VRDN · Real-Time Price · USD
18.00
-0.44 (-2.39%)
At close: Aug 15, 2025, 12:26 PM

Viridian Therapeutics Revenue

Viridian Therapeutics reported an annual revenue of $302K, reflecting a -3.82% growth. For the quarter ending June 30, 2025, Viridian Therapeutics generated $75K in revenue.
Revenue (ttm)
302K
Revenue Growth
-3.82%
Price / Sales Ratio
4309.19
Revenue / Employee
2.11K
Employees
143
Market Cap
1.47B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.